These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 36674535)

  • 41. Endothelial Dysfunction in Diabetic Retinopathy.
    Gui F; You Z; Fu S; Wu H; Zhang Y
    Front Endocrinol (Lausanne); 2020; 11():591. PubMed ID: 33013692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy.
    Amato R; Biagioni M; Cammalleri M; Dal Monte M; Casini G
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3066-76. PubMed ID: 27286364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetes-Induced Inflammation and Vascular Alterations in the Goto-Kakizaki Rat Retina.
    Hachana S; Pouliot M; Couture R; Vaucher E
    Curr Eye Res; 2020 Aug; 45(8):965-974. PubMed ID: 31902231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
    Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
    Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of lipopolysaccharides in diabetic retinopathy.
    Qin X; Zou H
    BMC Ophthalmol; 2022 Feb; 22(1):86. PubMed ID: 35193549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurovascular regulation in diabetic retinopathy and emerging therapies.
    Ji L; Tian H; Webster KA; Li W
    Cell Mol Life Sci; 2021 Aug; 78(16):5977-5985. PubMed ID: 34230991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular endothelial growth factor-A
    Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
    Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of VEGF-A in endothelial phenotypic shift in human diabetic retinopathy and VEGF-A-induced retinopathy in monkeys.
    Hofman P; Blaauwgeers HG; Vrensen GF; Schlingemann RO
    Ophthalmic Res; 2001; 33(3):156-62. PubMed ID: 11340407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. VEGF localisation in diabetic retinopathy.
    Boulton M; Foreman D; Williams G; McLeod D
    Br J Ophthalmol; 1998 May; 82(5):561-8. PubMed ID: 9713066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy.
    Sachdeva MM
    Curr Diab Rep; 2021 Dec; 21(12):65. PubMed ID: 34902066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autocrine and Paracrine Secretion of Vascular Endothelial Growth Factor in the Pre-Hypoxic Diabetic Retina.
    Grigsby JG; Allen DM; Ferrigno AS; Vellanki S; Pouw CE; Hejny WA; Tsin ATC
    Curr Diabetes Rev; 2017; 13(2):161-174. PubMed ID: 27748176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retinal redox stress and remodeling in cardiometabolic syndrome and diabetes.
    Yang Y; Hayden MR; Sowers S; Bagree SV; Sowers JR
    Oxid Med Cell Longev; 2010; 3(6):392-403. PubMed ID: 21307645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelial glycocalyx in retina, hyperglycemia, and diabetic retinopathy.
    Kaur G; Harris NR
    Am J Physiol Cell Physiol; 2023 May; 324(5):C1061-C1077. PubMed ID: 36939202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Norman MacAlister Gregg Lecture. The pathogenesis of diabetic retinopathy.
    Larkins RG; Dunlop ME; Johnson EI
    Aust N Z J Ophthalmol; 1996 May; 24(2):97-104. PubMed ID: 9199738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
    Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
    Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
    Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
    Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The ginger extract could improve diabetic retinopathy by inhibiting the expression of e/iNOS and G6PDH, apoptosis, inflammation, and angiogenesis.
    Ma H; Li J
    J Food Biochem; 2022 May; 46(5):e14084. PubMed ID: 35060143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
    Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
    Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.